Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0000950170-25-029434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-27 | 2024-02-25+ | FLGT | Xie Jian | Pres, COO | F - Tax | $16.28 | -17.4K | 347.6K | -5% | -$282.5K |
| M | 2025-02-27 | 2025-02-25 | FLGT | Xie Jian | Pres, COO | A - Grant | $0.00 | +68.5K | 352.4K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-25 | F | D | 8,031 | $16.29 | 339,585 | D | — | — | (F6) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024. |
| 2 | Common | Common Stock | 2025-02-25 | A | A | 45,304 | $0.00 | 384,889 | D | — | — | (F7) Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. |
| 3 | Common | Common Stock | 2024-02-26 | F | D | 4,551 | $16.24 | 380,338 | D | — | — | (F8) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. |
| 4 | Common | Common Stock | 2025-02-25 | A | A | 3,384 | $0.00 | 332,613 | D | — | — | (F1) Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022. |
| 5 | Common | Common Stock | 2025-02-25 | A | A | 5,480 | $0.00 | 338,093 | D | — | — | (F2) Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. |
| 6 | Common | Common Stock | 2025-02-25 | A | A | 14,297 | $0.00 | 352,390 | D | — | — | (F3) Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. |
| 7 | Common | Common Stock | 2025-02-25 | F | D | 1,823 | $16.29 | 350,567 | D | — | — | (F4) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022. |
| 8 | Common | Common Stock | 2024-02-25 | F | D | 2,951 | $16.29 | 347,616 | D | — | — | (F5) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023. |